Polaris Market Research today announced findings from its latest report, projecting the global branded generics market to grow from USD 265.9 billion in 2024 to USD 410.86 billion by 2032, registering a CAGR of 5.6% during the forecast period. The market is being shaped by the rising prevalence of chronic diseases, increasing demand for affordable medicines, patent expirations, government...